Oraverse (phentolamine mesylate) has been on the US market for over two years now and was recently introduced in Europe. It has been a tremendous marketing tool for many practices and there are patients stating they will never have dental anesthesia again without it.
Course fee: $49.00
In this course you will learn the science behind how this drug works with data from FDA studies, what the general public thinks from in-depth market analyses and its safety through a long history in medicine. You will also gain insight into various business implementation models that have been successful in practices across the country.
Learning objectives:
Expected duration of soft tissue vs pulpal anesthesia for most commonly used local anesthetics;
Mechanism of action for Oraverse (phentolamine mesylate);
Clinical indications in dentistry and the historical use of phentolamine.
ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry.
Print
Share
